Patents Assigned to HONGYUN BIOTECH CO., LTD.
  • EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20230310428
    Abstract: A compound represented by the following general formula, a preparation method thereof, a pharmaceutical composition containing the compound, and a use of the compound in preparation of drugs for preventing and/or treating EGFR kinase-mediated cancers and other diseases.
    Type: Application
    Filed: May 24, 2021
    Publication date: October 5, 2023
    Applicant: HONGYUN BIOTECH CO., LTD.
    Inventors: Xianming DENG, Wei HUANG, Zhenhua WU, Yachuang WU, Caihong YUN, Jianming ZHANG, Xin HUANG
  • Thienopyrimidine compound, preparation method thereof, pharmaceutical composition and application thereof
    Patent number: 11078213
    Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: August 3, 2021
    Assignee: HONGYUN BIOTECH CO., LTD.
    Inventors: Xianming Deng, Baoding Zhang, Shuang Liu, Chao Dong, Xihuan Sun, Xiaoxing Huang, Zhou Deng, Yunzhan Li, Yue Lu, Li Li, Zhiyu Hu
  • THIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
    Publication number: 20200207779
    Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.
    Type: Application
    Filed: September 28, 2017
    Publication date: July 2, 2020
    Applicant: HONGYUN BIOTECH CO., LTD.
    Inventors: Xianming DENG, Baoding ZHANG, Shuang LIU, Chao DONG, Xihuan SUN, Xiaoxing HUANG, Zhou DENG, Yunzhan LI, Yue LU, Li LI, Zhiyu HU
  • THIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
    Publication number: 20190211030
    Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.
    Type: Application
    Filed: September 28, 2017
    Publication date: July 11, 2019
    Applicant: HONGYUN BIOTECH CO., LTD.
    Inventors: Xianming DENG, Baoding ZHANG, Shuang LIU, Chao DONG, Xihuan SUN, Xiaoxing HUANG, Zhou DENG, Yunzhan LI, Yue LU, Li LI, Zhiyu HU